As we age, a subset of cells stops dividing but refuses to die. These senescent cells—often called "zombie cells"—secrete a cocktail of inflammatory molecules collectively known as the senescence-associated secretory phenotype (SASP).

SASP factors damage neighboring healthy tissue, promote chronic inflammation, and contribute to virtually every age-related disease: osteoarthritis, cardiovascular disease, frailty, and cognitive decline.

How Senolytics Work

Senolytics are compounds that selectively induce apoptosis (programmed cell death) in senescent cells while sparing healthy cells. The most studied combinations include:

• Dasatinib + Quercetin (D+Q) — the pioneering senolytic cocktail from Mayo Clinic research
• Fisetin — a flavonoid found in strawberries, studied as a standalone senolytic

In mouse models, intermittent senolytic treatment extended healthspan, improved physical function, and reduced age-related pathology across multiple organ systems.

What You Can Consider Today

For health-conscious adults exploring senolytics, the current evidence supports a cautious, intermittent approach:

Fisetin protocol (most accessible)

• Dose: 500–1000 mg/day for 2 consecutive days
• Frequency: Once per month (some protocols use every 2 weeks)
• Timing: Take with a fat-containing meal for absorption
• Quality: Use third-party tested supplements only

Lifestyle senolytics (free and proven)

Exercise—particularly high-intensity interval training—activates autophagy and helps clear damaged cells. Fasting (16–48 hours) also triggers cellular cleanup pathways that overlap with senolytic mechanisms.

Risks and Open Questions

Senolytics are powerful. Removing senescent cells is generally beneficial, but some senescent cells play roles in wound healing and tumor suppression. Long-term safety data in healthy humans does not yet exist.

Do not use senolytics if you are:

• Pregnant or breastfeeding
• Undergoing active cancer treatment (without oncologist approval)
• Taking multiple prescription medications without physician review

Reference:

Kirkland JL, Tchkonia T. Nature Medicine, 2020 — Senolytic drugs: the first decade. Zhu Y, et al. Aging Cell, 2017 — Fisetin is a senotherapeutic that extends healthspan in mice.

Key Takeaways

• Senescent cells accumulate with age and drive chronic inflammation through SASP secretion
• Senolytics selectively clear these cells; fisetin is the most accessible option for self-experimentation
• Intermittent dosing (not daily) appears to be the preferred approach based on current research
• Lifestyle interventions like exercise and fasting activate overlapping cleanup pathways safely